Rick Simpson Oil (RSO) for Cancer: Claims vs. Evidence, Risks, and Medical Perspective

Rick Simpson Oil (RSO) is a high-THC cannabis extract promoted as a cancer cure. Scientific evidence does not support curative claims in humans.

Preclinical Data Only

• In vitro: THC/CBD induce apoptosis, inhibit proliferation in some cancer cell lines.
• Animal models: reduced tumor growth in xenografts (glioma, breast, lung).
• No human clinical trials demonstrate tumor regression or survival benefit.

Potential Symptom Benefits

Cannabinoids may help with chemotherapy-induced nausea/vomiting (dronabinol/nabilone FDA-approved), neuropathic pain, appetite stimulation, anxiety, insomnia. RSO's unstandardized composition makes dosing unpredictable.

Risks & Concerns

• Psychoactive effects: impairment, anxiety, psychosis risk
• Drug interactions: CYP450 metabolism affects chemo, anticoagulants, anticonvulsants
• Contaminants: pesticides, heavy metals, solvents in unregulated products
• Delay of proven therapy: patients may forgo effective treatment
• Legal status varies; not a prescribed medication

Medical Position

Oncology guidelines support cannabinoids for symptom management, not as anticancer therapy. If considering cannabis, use regulated medical products with known THC:CBD ratios under physician supervision—never as a replacement for standard care.